Cancer Family
Skin Neoplasm
CI-CAN-00000051Explore in graph →
Non-malignant347 active trials14 approved drugs74 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000051Explore in graph →
Clinical trials
1,424 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02324608 | Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer | completed | N/A | 15 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT02839720 | Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Dec 6, 2023 | clinicaltrials |
| NCT03229278 | Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma | completed | Phase 1 | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT06152367 | Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients | completed | Phase 1 / Phase 2 | 90 | University of ChileOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT01523223 | Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies | completed | Phase 1 | 16 | Robert LowskyOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT00047060 | Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome | completed | Phase 1 / Phase 2 | 5 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Nov 14, 2023 | clinicaltrials |
| NCT03701295 | Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement | completed | Phase 1 / Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Oct 18, 2023 | clinicaltrials |
| NCT02304458 | Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas | completed | Phase 1 / Phase 2 | 140 | National Cancer Institute (NCI)NIH | 2 | Oct 17, 2023 | clinicaltrials |
| NCT01000753 | Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma | completed | — | 174 | Children's Oncology GroupNETWORK | 4 | Oct 3, 2023 | clinicaltrials |
| NCT03602079 | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | completed | Phase 1 / Phase 2 | 49 | Klus Pharma Inc.INDUSTRY | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04793529 | Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study | completed | N/A | 60 | Benha UniversityOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT04576416 | Artificial Intelligence Augmented Training in Skin Cancer Diagnostics for General Practitioners(AISC-GP) | completed | N/A | 115 | Herlev HospitalOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT04456140 | Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study | completed | Phase 1 | 230 | Mayo ClinicOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05493826 | Real World Study on the Use of Cemiplimab in Adult Patients in UK(REACT-CEMI) | completed | — | 110 | SanofiINDUSTRY | 1 | Jul 14, 2023 | clinicaltrials |
| NCT03419637 | Mobile Devices as Educational Skin History Tools | completed | N/A | 70 | University of PennsylvaniaOTHER | 1 | Jun 29, 2023 | clinicaltrials |
| NCT05788939 | PLANNED VISUAL EDUCATION ABOUT SKIN CANCER | completed | N/A | 116 | Manisa Celal Bayar UniversityOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05380635 | PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma | completed | Phase 2 | 9 | SoligenixINDUSTRY | 1 | Jun 7, 2023 | clinicaltrials |
| NCT00071071 | Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin. | completed | Phase 2 | 25 | GenmabINDUSTRY | 1 | May 18, 2023 | clinicaltrials |
| NCT00896493 | Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma | completed | Phase 2 | 38 | Stanford UniversityOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT05389085 | Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping | completed | N/A | 75 | University Hospital Bispebjerg and FrederiksbergOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05842421 | Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors | completed | N/A | 250 | Technische Universität DresdenOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT00071084 | Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin. | completed | Phase 2 | 22 | GenmabINDUSTRY | 4 | Apr 28, 2023 | clinicaltrials |
| NCT00392561 | Bangladesh Vitamin E and Selenium Trial(BEST) | completed | N/A | 7,000 | University of ChicagoOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT02546440 | Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)(DMF-CTCL) | completed | Phase 2 | 25 | Universitätsmedizin MannheimOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT03122366 | TLR4 Polymorphisms and Risk of Skin Cancer | completed | — | 392 | University of Alabama at BirminghamOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT01662713 | Optical Frequency Domain Imaging for Non-melanoma Skin Cancers(OFDI) | completed | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 15, 2023 | clinicaltrials |
| NCT05115669 | Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts | completed | N/A | 50 | Karo Pharma ABINDUSTRY | 1 | Feb 21, 2023 | clinicaltrials |
| NCT04932746 | The Effect of Dexmedetomidine on Oxygen During One Lung Ventilation in Pediatric Surgery.(RCT) | completed | N/A | 110 | Damascus UniversityOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT03096548 | Sun Safety Ink! A Sun Safety Program for the Tattoo Community | completed | N/A | 1,820 | Klein Buendel, Inc.INDUSTRY | 1 | Feb 6, 2023 | clinicaltrials |
| NCT05303480 | Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides | completed | N/A | 32 | Centre for Human Drug Research, NetherlandsOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT02032810 | Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma | completed | Phase 1 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT02941900 | Interest and Impact of Skin Cancer Genetic Testing | completed | — | 53 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT03109353 | Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease | completed | Phase 1 / Phase 2 | 7 | St. Olavs HospitalOTHER | 1 | Jan 13, 2023 | clinicaltrials |
| NCT04918381 | CellFX Treat & Resect Low-Risk BCC Feasibility Study | completed | N/A | 30 | Pulse Biosciences, Inc.INDUSTRY | 1 | Jan 11, 2023 | clinicaltrials |
| NCT03281811 | Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides | completed | Early Phase 1 | 11 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT03843593 | A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery | completed | — | 38 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT04185220 | Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome | completed | Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Jan 4, 2023 | clinicaltrials |
| NCT02643303 | A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers | completed | Phase 1 / Phase 2 | 58 | Ludwig Institute for Cancer ResearchOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT04978740 | Ocular and Palpebral Manifestations of Mastocytosis (MOOMA) | completed | N/A | 21 | Poitiers University HospitalOTHER | 1 | Dec 1, 2022 | clinicaltrials |
| NCT05068687 | Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT | completed | N/A | 9 | University Hospital, GhentOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05628714 | A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma | completed | — | 222 | Maastricht University Medical CenterOTHER | 1 | Nov 29, 2022 | clinicaltrials |
| NCT03457766 | Presurgical Evaluation of Skin Cancers Using HIFU | completed | N/A | 40 | Assiut UniversityOTHER | 1 | Nov 25, 2022 | clinicaltrials |
| NCT01807182 | Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 11 | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 10, 2022 | clinicaltrials |
| NCT05146622 | Virtual Sun Safe Workplaces Ph I(SSW Works) | completed | — | 104 | Klein Buendel, Inc.INDUSTRY | 1 | Nov 4, 2022 | clinicaltrials |
| NCT00633516 | A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions | completed | — | 37 | University of California, IrvineOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT00784108 | Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry. | completed | Phase 1 | 11 | University of California, IrvineOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT02244749 | Role of Metabolic Enzymes in Non-Melanoma Skin Cancer | completed | — | 26 | University of California, IrvineOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT00520299 | Study of ADI-PEG 20 in Patients With Advanced Melanoma | completed | Phase 1 / Phase 2 | 31 | Ludwig Institute for Cancer ResearchOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT00540566 | Optical Biopsy of Human Skin in Conjunction With Laser Treatment | completed | — | 113 | University of California, IrvineOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT02835807 | Engaging Moms on Teen Indoor Tanning Through Social Media | completed | N/A | 1,607 | Klein Buendel, Inc.INDUSTRY | 1 | Oct 20, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Dec 20, 2023source: clinicaltrials